LB Pharmaceuticals Ownership | Who Owns LB Pharmaceuticals?


OverviewChart

LB Pharmaceuticals Ownership Summary


LB Pharmaceuticals is owned by 78.84% institutional investors, and 21.16% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.85% of LBRX shares.

LBRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLB Pharmaceuticals78.84%-21.16%
SectorHealthcare Stocks 42.64%10.86%46.50%
IndustryBiotech Stocks 45.45%10.77%43.78%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de2.24M8.85%$49.84M
Jpmorgan chase1.61M6.37%$35.87M
Vanguard group1.11M4.40%$24.77M
Jennison associates821.85K3.25%$18.29M
Nantahala capital management675.00K2.67%$15.03M
Geode capital management441.45K1.74%$9.83M
Goldman sachs group303.12K1.20%$6.75M
Longbow finance sa82.34K0.33%$1.83M
Ubs group50.71K0.20%$1.13M
Bank of new york mellon40.52K0.16%$901.91K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nantahala capital management675.00K0.50%$15.03M
Longbow finance sa82.34K0.31%$1.83M
Jennison associates821.85K0.01%$18.29M
Soleus capital management10.00K0.01%$222.60K
Jpmorgan chase1.61M0.00%$35.87M
Jefferies financial group12.45K0.00%$277.03K
Metlife investment management11.10K0.00%$247.18K
Ameritas investment partners1.56K0.00%$34.77K
Goldman sachs group303.12K0.00%$6.75M
Blackrock funding, inc. /de2.24M0.00%$49.84M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de2.24M0.00%1.26M
Vanguard group1.11M0.00%1.11M
Jpmorgan chase1.61M0.00%578.88K
Geode capital management441.45K0.00%427.86K
Jennison associates821.85K0.01%82.81K

Top Sellers

HolderShares% AssetsChange
Soleus capital management10.00K0.01%-390.00K
Silverarc capital management---70.00K
Hrt financial lp---58.81K
Goldman sachs group303.12K0.00%-40.41K
Monashee investment management---40.00K

New Positions

HolderShares% AssetsChangeValue
Vanguard group1.11M0.00%1.11M$24.77M
Longbow finance sa82.34K0.31%82.34K$1.83M
Bank of new york mellon40.52K0.00%40.52K$901.91K
Nuveen22.97K0.00%22.97K$511.22K
Norges bank20.00K-20.00K$445.20K

Sold Out

HolderChange
Quarry lp-11.00
Landscape capital management-10.64K
Manufacturers life insurance company, the-17.49K
Squarepoint ops-20.82K
Hudson bay capital management lp-27.10K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202553-19,945,854-78-53---

LBRX Ownership FAQ


Who Owns LB Pharmaceuticals?

LB Pharmaceuticals shareholders are primarily institutional investors at 78.84%, followed by 0% insiders and 0% retail investors. The average institutional ownership in LB Pharmaceuticals's industry, Biotech Stocks , is 45.45%, which LB Pharmaceuticals exceeds.

Who owns the most shares of LB Pharmaceuticals?

LB Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (2.24M shares, 8.85%), Jpmorgan chase (1.61M shares, 6.37%), and Vanguard group (1.11M shares, 4.40%). Together, they hold 19.62% of LB Pharmaceuticals’s total shares outstanding.

Does Blackrock own LB Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of LB Pharmaceuticals.

Who is LB Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Nantahala capital management is LB Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.50% of its assets in 675K LB Pharmaceuticals shares, valued at 15.03M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools